MNKD vs TECH · rev $285.5M vs P/E 65, rev $1.22B
MannKind Corp (MNKD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
MannKind Corp (MNKD) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MNKD revenue for 2024-12-31 was $285.5M. Net income was $27.6M. Revenue was up 43.5% from 2023-12-31 to 2024-12-31. MNKD currently screens at market cap $1.28B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MNKD currently screens at market cap $1.28B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MNKD and TECH stock pages for the full models.
Not investment advice.